Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026)
Green Thumb Industries (GTBIF) reported Other Non-Current Assets of $4.4 million for Q1 2026, up 1.63% on a YoY basis from $4.4 million in Q1 2025, and up 111.25% quarter-over-quarter from $2.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Other Non-Current Assets for 8 years, with the latest figure at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 1.63% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 1.63% YoY), and the FY2025 full-year result was $2.1 million, down 3.23% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $4.4 million, up from $2.1 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $9.2 million in Q3 2025, with the low at $2.0 million in Q2 2025.
- Historically, Other Non-Current Assets has averaged $3.2 million across 5 years, with a median of $2.6 million in 2022.
- The largest YoY upside for Other Non-Current Assets was 69.54% in 2025 against a maximum downside of 21.57% in 2025.
- Green Thumb Industries' Other Non-Current Assets stood at $3.1 million in 2022, then decreased by 16.44% to $2.6 million in 2023, then slipped by 15.25% to $2.2 million in 2024, then slipped by 3.23% to $2.1 million in 2025, then jumped by 111.25% to $4.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $4.4 million (Q1 2026), $2.1 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 4.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.43 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 4.36 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.87 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Mar 31, 2021 | 2.26 Mn |